Key Metrics
0.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q4
Oncology
SJR
- Q4 Oncology
- Q4 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.16
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Breast cancer
- Neuroendocrine tumors
- Irradiation
- Small intestine
- X-ray
- Overall survival
- Surgical treatment
- Preoperative chemotherapy
- Primary tumor
- Cervical cancer
- Breast cancer screening
- Triple-negative breast cancer
- Colorectal cancer
Journal Specifications
| Overview | |
| Publisher | Via Medica |
| Language | English |
| Publication Time | 11 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Polish Oncological Society |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 11 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Double anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Publisher's own |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Nowotwory ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Advanced renal cancer as a chronic disease — long-term disease control with a tyrosine kinase inhibitor (TKI) inhibitor
- 30 Oct 24
- Nowotwory. Journal of Oncology
-
Full paper
The existence of “bosom malignancy” — a “tortured phrase” in breast cancer literature
- 30 Oct 24
- Nowotwory. Journal of Oncology
-
Full paper
Integrating smoking cessation counseling into oncology practice — benefits and barriers
- 22 Oct 24
- Nowotwory. Journal of Oncology
-
Full paper
The expression of CDX-2 and p53 immunohistochemical markers — a useful diagnostic tool for glandular dysplasia in Barrett’s oesophagus
- 18 Oct 24
- Nowotwory. Journal of Oncology
-
Full paper
Do malignant tumors need oxygen to survive radiotherapy?
- 18 Oct 24
- Nowotwory. Journal of Oncology
-
Full paper
Expression of cancer testis genes in gastric neoplasms — a preliminary study
- 26 Sep 24
- Nowotwory. Journal of Oncology
Scite analysis
Powered by scite_
767 articles received 1.1k citations see all
- 19 Supporting
- 754 Mentioning
- 4 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How many articles did Nowotwory publish last years ?
In 2023, Nowotwory published 60 articles.
What is the eISSN & pISSN for Nowotwory ?
For Nowotwory,eISSN is 2300-2115 and pISSN is0029-540X.
What is Citescore for Nowotwory ?
Citescore for Nowotwory is 0.3.
What is SNIP score for Nowotwory ?
SNIP score for Nowotwory is 0.16.
What is the SJR for Nowotwory ?
SJR for Nowotwory is Q4.
Who is the publisher of Nowotwory ?
Via Medica is the publisher of Nowotwory.